INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

82,042 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
BC
Bonner ChrisSVP, CFO, and Treasurer
BSMBlack Stone Minerals, L.P.
Grant or award
A—
42.7K sh
Feb 4, 2026Feb 6, 2026
Page 1598 of 2052
← PrevNext →
traded Feb 4, 2026
+2d
SEC Form 4

Evidence

21
PR
Putnam Leah RChief Accounting Officer
BBBYBED BATH & BEYOND, INC.
Option exercise
M$7.53
7,530 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

21
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Option exercise
M$5.24
5,238 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

21
SM
Skeete Bernard MChief Accounting Officer
VLTOVeralto Corp
Grant or award
A—
255 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

20
JL
Johnson Margaret LDirector
BLKBlackRock, Inc.
Gift
G—
419 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

20
LH
Lamb William HDirector
TBBKBancorp, Inc.
Gift
G—
2,400 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

20
Virginia FoxxRSelf
PSAPublic Storage
Sale
SELL$1,001 – $15KJan 12, 2026Feb 6, 2026
traded Jan 12, 2026
+25dHouse PTR

Evidence

20
JL
Johnson Margaret LDirector
BLKBlackRock, Inc.
Gift
G—
419 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

19
OL
Oliver Robin LeighDirector, President, COO
BAFNBayFirst Financial Corp.
Tax withholding
F$802
119 sh
Jan 27, 2026Feb 6, 2026
traded Jan 27, 2026
+10dSEC Form 4

Evidence

19
OL
Oliver Robin LeighDirector, President, COO
BAFNBayFirst Financial Corp.
Tax withholding
F$812
119 sh
Jan 26, 2026Feb 6, 2026
traded Jan 26, 2026
+11dSEC Form 4

Evidence

19
KS
Klaus Andrew SCFO
PLPCPREFORMED LINE PRODUCTS CO
Tax withholding
F$367K
1,496 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

19
MJ
McKim Scott JosephEVP, Chief Financial Officer
BAFNBayFirst Financial Corp.
Tax withholding
F$503
75 sh
Jan 23, 2026Feb 6, 2026
traded Jan 23, 2026
+14dSEC Form 4

Evidence

19
DM
David MosheDirector
KDOZFKIDOZ INC.
Expiration of short derivative
E$20K
50.0K sh
Feb 1, 2026Feb 6, 2026
traded Feb 1, 2026
+5dSEC Form 4

Evidence

19
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$349K
996 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

19
BE
Ben Tora EldadDirector, President & General Manager EM
KDOZFKIDOZ INC.
Expiration of short derivative
E$20K
50.0K sh
Feb 1, 2026Feb 6, 2026
traded Feb 1, 2026
+5dSEC Form 4

Evidence

19
OL
Oliver Robin LeighDirector, President, COO
BAFNBayFirst Financial Corp.
Tax withholding
F$812
119 sh
Jan 26, 2026Feb 6, 2026
traded Jan 26, 2026
+11dSEC Form 4

Evidence

19
WJ
Wagnes Michael J.SVP and CFO
ALLEAllegion plc
Tax withholding
F$475K
2,773 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

19
OL
Oliver Robin LeighDirector, President, COO
BAFNBayFirst Financial Corp.
Tax withholding
F$898
134 sh
Jan 23, 2026Feb 6, 2026
traded Jan 23, 2026
+14dSEC Form 4

Evidence

19
ZG
Zernick Thomas GerardDirector, CEO
BAFNBayFirst Financial Corp.
Tax withholding
F$5,919
890 sh
Feb 3, 2026Feb 6, 2026
traded Feb 3, 2026
+3dSEC Form 4

Evidence

18
FE
Forminard ElizabethEVP, Chief Legal Officer
JNJJOHNSON & JOHNSON
Option exercise
M$1.16M
8,921 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

18
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale · 10b5-1 plan
SELL$9,192
100 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

18
JD
Jenkins Mark DavidCo-President
CGCarlyle Group Inc.
Tax withholding
F$2.56M
46.2K sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

18
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale · 10b5-1 plan
SELL$9,045
100 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

18
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale · 10b5-1 plan
SELL$29K
328 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

18
GA
Gottschalk AdrianDirector, Chief Executive Officer
FHTXFoghorn Therapeutics Inc.
Grant or award
A$5.62M
1.07M sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

17
GS
Grant SeanCHIEF FINANCIAL OFFICER
VERAVera Therapeutics, Inc.
Grant or award
A—
25.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
LC
Lee CindyChief Financial Officer
VIRTVirtu Financial, Inc.
Tax withholding
F—
6,274 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
HL
Hawes Jennifer LSVP - Chief HR Officer
ALLEAllegion plc
Grant or award
A—
2,777 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
TS
Trivedi SurekhaSVP, Strategy & Sustainability
VLTOVeralto Corp
Grant or award
A—
537 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

17
SH
Stone John HDirector, President and CEO
ALLEAllegion plc
Grant or award
A—
30.5K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
LC
Lee CindyChief Financial Officer
VIRTVirtu Financial, Inc.
Option exercise
M—
12.5K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale · 10b5-1 plan
SELL$119K
1,425 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
PR
Putnam Leah RChief Accounting Officer
BBBYBED BATH & BEYOND, INC.
Option exercise
M$5.81
5,811 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale · 10b5-1 plan
SELL$54K
623 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
WJ
Wagnes Michael J.SVP and CFO
ALLEAllegion plc
Grant or award
A—
8,328 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
OP
O'Meara Brien P.Vice President & Controller
PHMPULTEGROUP INC/MI/
Grant or award
A—
4,489 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
MC
Martens Robert C.SVP-Chief Innovation & Design
ALLEAllegion plc
Grant or award
A—
3,054 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
SM
Skelton Laurence MatthewChief Commercial Officer
VERAVera Therapeutics, Inc.
Grant or award
A—
20.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Grant or award
A—
68.8K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
SA
Strausbaugh Sue AnnDirector
SBFGSB FINANCIAL GROUP, INC.
Grant or award
A$1,107
50 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence